Ladenburg Thalmann Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Ladenburg Thalmann Financial Services's PFE Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its Pfizer (PFE) stake by 2.5% in Q4 2019, selling an estimated $813K and leaving 890,961 shares worth $32.9M. The position accounts for 0.21% of the portfolio, ranked #110.
Ladenburg Thalmann Financial Services first reported a position in PFE in Q2 2013 and has held it in 27 quarters since. The position peaked at $37.2M in Q2 2019. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.
- Ladenburg Thalmann Financial Services held 890,961 shares of Pfizer worth $32.9M as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 22,837 Pfizer shares in Q4 2019, an estimated $813K.
- Pfizer made up 0.21% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #110 holding.
- Ladenburg Thalmann Financial Services first reported a position in Pfizer in Q2 2013 and has held it in 27 quarters since.
- Ladenburg Thalmann Financial Services's Pfizer position peaked at $37.2M in Q2 2019.
- 2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.